{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:05:22Z","timestamp":1790643922277,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T00:00:00Z","timestamp":1672876800000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["HHSN275201300006C"],"award-info":[{"award-number":["HHSN275201300006C"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ajog.2021.01.020","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T11:40:37Z","timestamp":1618573237000},"page":"126.e1-126.e22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study"],"prefix":"10.1016","volume":"226","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1712-7588","authenticated-orcid":false,"given":"Adi L.","family":"Tarca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Taran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunjung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Paredes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corina","family":"Ghita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinnakorn","family":"Chaiworapongsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandor Gabor","family":"Than","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaur-Dong","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2021.01.020_bib1","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1080\/14767050902784171","article-title":"Prenatal medicine: the child is the father of the man. 1996","volume":"22","author":"Romero","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1080\/14767050902866804","article-title":"The great obstetrical syndromes","volume":"22","author":"Di Renzo","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib3","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrneph.2014.102","article-title":"Pre-eclampsia part 1: current understanding of its pathophysiology","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2021.01.020_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116508","article-title":"Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia","volume":"10","author":"Leavey","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.01.020_bib5","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.3389\/fimmu.2018.01661","article-title":"Integrated systems biology approach identifies novel maternal and placental pathways of preeclampsia","volume":"9","author":"Than","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2021.01.020_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","article-title":"Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion","volume":"25","author":"Soto","year":"2012","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib7","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.ajog.2004.03.043","article-title":"Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award","volume":"190","author":"Chaiworapongsa","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib8","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrneph.2014.103","article-title":"Pre-eclampsia part 2: prediction, prevention and management","volume":"10","author":"Chaiworapongsa","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.ajog.2021.01.020_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/14767050400028816","article-title":"Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia","volume":"17","author":"Chaiworapongsa","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.ajog.2005.06.033","article-title":"An elevated maternal plasma, but not amniotic fluid, soluble fms-like tyrosine kinase-1 (sFlt-1) at the time of mid-trimester genetic amniocentesis is a risk factor for preeclampsia","volume":"193","author":"Park","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050500202493","article-title":"Evidence supporting that the excess of the sVEGFR-1 concentration in maternal plasma in preeclampsia has a uterine origin","volume":"18","author":"Bujold","year":"2005","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nm1429","article-title":"Soluble endoglin contributes to the pathogenesis of preeclampsia","volume":"12","author":"Venkatesha","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib13","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/14767050802034545","article-title":"The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age","volume":"21","author":"Erez","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/14767050701831397","article-title":"Low maternal concentrations of soluble vascular endothelial growth factor receptor-2 in preeclampsia and small for gestational age","volume":"21","author":"Chaiworapongsa","year":"2008","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A\u00a0prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib17","doi-asserted-by":"crossref","first-page":"550.e1","DOI":"10.1016\/j.ajog.2010.04.002","article-title":"A\u00a0decrease in maternal plasma concentrations of sVEGFR-2 precedes the clinical diagnosis of preeclampsia","volume":"202","author":"Chaiworapongsa","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3109\/14767058.2011.589932","article-title":"Maternal plasma concentrations of angiogenic\/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia","volume":"24","author":"Chaiworapongsa","year":"2011","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib19","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1172\/JCI70431","article-title":"Preeclampsia: a link between trophoblast dysregulation and an antiangiogenic state","volume":"123","author":"Romero","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2021.01.020_bib20","doi-asserted-by":"crossref","first-page":"287.e1","DOI":"10.1016\/j.ajog.2013.01.016","article-title":"Maternal plasma concentrations of angiogenic\/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia","volume":"208","author":"Chaiworapongsa","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3109\/14767058.2013.806905","article-title":"Plasma concentrations of angiogenic\/anti-angiogenic factors have prognostic value in women presenting with suspected preeclampsia to the obstetrical triage area: a prospective study","volume":"27","author":"Chaiworapongsa","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib22","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3109\/14767058.2015.1048431","article-title":"The use of angiogenic biomarkers in maternal blood to identify which SGA fetuses will require a preterm delivery and mothers who will develop pre-eclampsia","volume":"29","author":"Chaiworapongsa","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181468","article-title":"The prediction of late-onset preeclampsia: results from a longitudinal proteomics study","volume":"12","author":"Erez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.01.020_bib24","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1080\/14767058.2018.1427058","article-title":"The profiles of soluble adhesion molecules in the \u201cgreat obstetrical syndromes\u201d","volume":"32","author":"Docheva","year":"2019","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217273","article-title":"The prediction of early preeclampsia: results from a longitudinal proteomics study","volume":"14","author":"Tarca","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.01.020_bib26","doi-asserted-by":"crossref","first-page":"175.e1","DOI":"10.1016\/j.ajog.2007.08.052","article-title":"Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion","volume":"198","author":"Stepan","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/uog.14799","article-title":"Implementation of the sFlt-1\/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice","volume":"45","author":"Stepan","year":"2015","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib28","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/uog.17373","article-title":"sFlt-1\/PlGF for prediction of early-onset pre-eclampsia: STEPS (Study of Early Pre-eclampsia in Spain)","volume":"50","author":"Perales","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178528","article-title":"Revisiting the discriminatory accuracy of traditional risk factors in preeclampsia screening","volume":"12","author":"Rodriguez-Lopez","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2021.01.020_bib30","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/pd.2660","article-title":"Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11-13 weeks","volume":"31","author":"Akolekar","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2021.01.020_bib31","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00404-016-4128-4","article-title":"Using the angiogenic factors sFlt-1 and PlGF with Doppler ultrasound of the uterine artery for confirming preeclampsia","volume":"294","author":"Bahlmann","year":"2016","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.01.020_bib32","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/uog.17455","article-title":"Multicenter screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation: comparison with NICE guidelines and ACOG recommendations","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib33","doi-asserted-by":"crossref","first-page":"87.e1","DOI":"10.1016\/j.ajog.2016.02.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 30-34 weeks\u2019 gestation","volume":"215","author":"Tsiakkas","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib34","doi-asserted-by":"crossref","first-page":"62.e1","DOI":"10.1016\/j.ajog.2015.02.018","article-title":"Competing risks model in screening for preeclampsia by maternal characteristics and medical history","volume":"213","author":"Wright","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib35","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib36","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/uog.17399","article-title":"Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11-13 weeks\u2019 gestation","volume":"49","author":"O\u2019Gorman","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib37","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/uog.19112","article-title":"Screening for pre-eclampsia by maternal factors and biomarkers at 11\u201313\u2009weeks\u2019 gestation","volume":"52","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib39","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib40","doi-asserted-by":"crossref","first-page":"585.e1","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib41","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib42","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000336662","article-title":"Early administration of low-dose aspirin for the prevention of preterm and term preeclampsia: a systematic review and meta-analysis","volume":"31","author":"Roberge","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2021.01.020_bib43","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/AOG.0000000000001711","article-title":"Practice Bulletin No. 171: Management of preterm labor","volume":"128","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib44","doi-asserted-by":"crossref","first-page":"415.e1","DOI":"10.1016\/j.ajog.2017.01.008","article-title":"Early standardized treatment of critical blood pressure elevations is associated with a reduction in eclampsia and severe maternal morbidity","volume":"216","author":"Shields","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib45","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0002-9378(90)90002-O","article-title":"Magnesium sulfate is the ideal anticonvulsant in preeclampsia-eclampsia","volume":"162","author":"Sibai","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib46","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.ajog.2009.04.005","article-title":"Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks\u2019 gestation: a systematic review and metaanalysis","volume":"200","author":"Conde-Agudelo","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib47","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0140-6736(09)60736-4","article-title":"Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks\u2019 gestation (HYPITAT): a multicentre, open-label randomised controlled trial","volume":"374","author":"Koopmans","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.01.020_bib48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/uog.17309","article-title":"Proposed clinical management of pregnancies after combined screening for pre-eclampsia at 30-34 weeks\u2019 gestation","volume":"49","author":"Wright","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib49","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/uog.15812","article-title":"Competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 35-37 weeks\u2019 gestation","volume":"48","author":"Andrietti","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib50","doi-asserted-by":"crossref","first-page":"619.e1","DOI":"10.1016\/j.ajog.2015.11.016","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 19-24 weeks\u2019 gestation","volume":"214","author":"Gallo","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajog.2019.11.1247","article-title":"The competing risk approach for prediction of preeclampsia","volume":"223","author":"Wright","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib52","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000324320","article-title":"Turning the pyramid of prenatal care","volume":"29","author":"Nicolaides","year":"2011","journal-title":"Fetal Diagn Ther"},{"issue":"Suppl 1","key":"10.1016\/j.ajog.2021.01.020_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijgo.12802","article-title":"The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: a pragmatic guide for first-trimester screening and prevention","volume":"145","author":"Poon","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1016\/j.ajog.2021.01.020_bib54","doi-asserted-by":"crossref","first-page":"629.e1","DOI":"10.1016\/j.ajog.2015.11.015","article-title":"Maternal plasma angiogenic index-1 (placental growth factor\/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study","volume":"214","author":"Korzeniewski","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib55","doi-asserted-by":"crossref","first-page":"820","DOI":"10.3109\/14767050903366119","article-title":"Serum and plasma determination of angiogenic and antiangiogenic factors yield different results: the need for standardization in clinical practice","volume":"23","author":"Ogg\u00e8","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib56","first-page":"159","article-title":"ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002","volume":"99","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib57","first-page":"429","article-title":"Regression using fractional polynomials of continuous covariates: parsimonious parametric modelling","volume":"43","author":"Royston","year":"1994","journal-title":"J\u00a0R Stat Soc C"},{"key":"10.1016\/j.ajog.2021.01.020_bib58","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.bpobgyn.2011.02.006","article-title":"Placental bed disorders in preterm labor, preterm PROM, spontaneous abortion and abruptio placentae","volume":"25","author":"Romero","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib59","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1067\/mob.2002.127720","article-title":"Failure of physiologic transformation of the spiral arteries in the placental bed in preterm premature rupture of membranes","volume":"187","author":"Kim","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib60","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.3109\/14767058.2014.976198","article-title":"The frequency of acute atherosis in normal pregnancy and preterm labor, preeclampsia, small-for-gestational age, fetal death and midtrimester spontaneous abortion","volume":"28","author":"Kim","year":"2015","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib61","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1067\/S0002-9378(03)00838-X","article-title":"Failure of physiologic transformation of the spiral arteries in patients with preterm labor and intact membranes","volume":"189","author":"Kim","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib62","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1515\/JPM.2006.089","article-title":"Normal and abnormal transformation of the spiral arteries during pregnancy","volume":"34","author":"Espinoza","year":"2006","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib63","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201dGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib64","doi-asserted-by":"crossref","first-page":"682.e1","DOI":"10.1016\/j.ajog.2017.10.001","article-title":"The prediction of fetal death with a simple maternal blood test at 24-28 weeks: a role for angiogenic index-1 (PlGF\/sVEGFR-1 ratio)","volume":"217","author":"Chaiworapongsa","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib65","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1515\/jpm.2011.098","article-title":"Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsia","volume":"39","author":"Ogge","year":"2011","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib66","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/S0002-9378(03)00576-3","article-title":"The frequency and severity of placental findings in women with preeclampsia are gestational age dependent","volume":"189","author":"Moldenhauer","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib67","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ajog.2021.01.020_bib68","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0143-4004(80)80012-9","article-title":"Trophoblastic invasion of human decidua from 8 to 18 weeks of pregnancy","volume":"1","author":"Pijnenborg","year":"1980","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.01.020_bib69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1471-0528.1994.tb13182.x","article-title":"A\u00a0study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies","volume":"101","author":"Meekins","year":"1994","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2021.01.020_bib70","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.placenta.2008.11.003","article-title":"Placental endoplasmic reticulum stress and oxidative stress in the pathophysiology of unexplained intrauterine growth restriction and early onset preeclampsia","volume":"30","author":"Burton","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.01.020_bib71","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1471-0528.1998.tb09974.x","article-title":"Circulating markers of oxidative stress are raised in normal pregnancy and pre-eclampsia","volume":"105","author":"Morris","year":"1998","journal-title":"Br J Obstet Gynaecol"},{"issue":"Suppl","key":"10.1016\/j.ajog.2021.01.020_bib72","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.placenta.2013.12.008","article-title":"IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia?","volume":"35","author":"Redman","year":"2014","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.01.020_bib73","doi-asserted-by":"crossref","first-page":"527.e1","DOI":"10.1016\/j.ajog.2016.12.174","article-title":"Repeated measures of inflammation and oxidative stress biomarkers in preeclamptic and normotensive pregnancies","volume":"216","author":"Ferguson","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.08.003","article-title":"Preeclampsia, biomarkers, syncytiotrophoblast stress, and placental capacity","volume":"213","author":"Redman","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib75","first-page":"1100","article-title":"Endothelial damage\/dysfunction and hypertension in pregnancy","volume":"3","author":"Karthikeyan","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.ajog.2021.01.020_bib76","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1749-6632.2000.tb06314.x","article-title":"Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction","volume":"902","author":"Sato","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.ajog.2021.01.020_bib77","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.placenta.2010.02.020","article-title":"Secretion of angiogenic growth factors by villous cytotrophoblast and extravillous trophoblast in early human pregnancy","volume":"31","author":"Lash","year":"2010","journal-title":"Placenta"},{"issue":"Suppl A","key":"10.1016\/j.ajog.2021.01.020_bib78","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.placenta.2008.11.020","article-title":"Gabor Than Award Lecture 2008: pre-eclampsia\u2014from placental oxidative stress to maternal endothelial dysfunction","volume":"30","author":"Cindrova-Davies","year":"2009","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.01.020_bib79","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/uog.17517","article-title":"Impaired placentation in women with chronic hypertension who develop pre-eclampsia","volume":"50","author":"Panaitescu","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0002-9378(98)70254-6","article-title":"Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis","volume":"179","author":"Sacks","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib81","doi-asserted-by":"crossref","first-page":"293271","DOI":"10.1155\/2015\/293271","article-title":"Oxidative stress in placenta: health and diseases","volume":"2015","author":"Wu","year":"2015","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.ajog.2021.01.020_bib82","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/0002-9378(89)90665-0","article-title":"Preeclampsia: an endothelial cell disorder","volume":"161","author":"Roberts","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib83","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0143-4004(91)90339-H","article-title":"Current topic: pre-eclampsia and the placenta","volume":"12","author":"Redman","year":"1991","journal-title":"Placenta"},{"key":"10.1016\/j.ajog.2021.01.020_bib84","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/0140-6736(93)90889-O","article-title":"Pre-eclampsia: more than pregnancy-induced hypertension","volume":"341","author":"Roberts","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.01.020_bib85","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1161\/01.HYP.38.3.718","article-title":"Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction","volume":"38","author":"Granger","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.01.020_bib86","first-page":"1","article-title":"Maternal whole blood mRNA signatures identify women at risk of early preeclampsia: a longitudinal study","author":"Tarca","year":"2020","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib87","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/ajh\/hpx040","article-title":"Preeclampsia, portliness, and perturbation of adipose tissue function-are we beginning to connect the dots?","volume":"30","author":"Vaisbuch","year":"2017","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.ajog.2021.01.020_bib88","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0002-9378(96)70056-X","article-title":"Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications","volume":"175","author":"Ness","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bpobgyn.2011.01.005","article-title":"The origins and end-organ consequence of pre-eclampsia","volume":"25","author":"Eastabrook","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib90","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.5184","article-title":"Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction","volume":"31","author":"Crispi","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib91","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0140-6736(92)91342-6","article-title":"Customised antenatal growth charts","volume":"339","author":"Gardosi","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2021.01.020_bib92","doi-asserted-by":"crossref","first-page":"S679","DOI":"10.1016\/j.ajog.2017.12.229","article-title":"A\u00a0new customized fetal growth standard for African American women: the PRB\/NICHD Detroit study","volume":"218","author":"Tarca","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib93","article-title":"Personalized assessment of cervical length improves prediction of spontaneous preterm birth: a standard and a percentile calculator","author":"Gudicha","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib94","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"75","author":"Stepan","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.01.020_bib95","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ajog.2006.01.014","article-title":"Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction","volume":"195","author":"Crispi","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib96","doi-asserted-by":"crossref","first-page":"239.e1","DOI":"10.1016\/j.ajog.2006.10.909","article-title":"Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia","volume":"196","author":"Vatten","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib97","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/uog.6244","article-title":"Maternal serum placental growth factor at 11\u00a0+0 to 13\u00a0+6 weeks of gestation in the prediction of pre-eclampsia","volume":"32","author":"Akolekar","year":"2008","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2021.01.020_bib98","first-page":"2675101","article-title":"Evidence-based prevention of preeclampsia: commonly asked questions in clinical practice","volume":"2019","author":"Wertaschnigg","year":"2019","journal-title":"J\u00a0Pregnancy"},{"key":"10.1016\/j.ajog.2021.01.020_bib99","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0038-1675160","article-title":"Pregnancy outcomes of exacerbated chronic hypertension compared with superimposed preeclampsia","volume":"36","author":"Becker","year":"2019","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2021.01.020_bib100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1515\/jpme.1996.24.2.141","article-title":"Chronic hypertension in pregnancy: color Doppler investigation of uterine arteries as a predictive test for superimposed preeclampsia and adverse perinatal outcome","volume":"24","author":"Caruso","year":"1996","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ajog.2021.01.020_bib101","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/HYPERTENSIONAHA.111.181735","article-title":"Angiogenic factors in superimposed preeclampsia: a longitudinal study of women with chronic hypertension during pregnancy","volume":"59","author":"Perni","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2021.01.020_bib102","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/pd.2027","article-title":"Prediction of superimposed preeclampsia using uterine artery Doppler velocimetry in women with chronic hypertension","volume":"28","author":"Roncaglia","year":"2008","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2021.01.020_bib103","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/jmf.14.5.318.323","article-title":"Maternal and fetal artery Doppler findings in women with chronic hypertension who subsequently develop superimposed pre-eclampsia","volume":"14","author":"Zeeman","year":"2003","journal-title":"J\u00a0Matern Fetal Neonatal Med"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821000752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937821000752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:36:15Z","timestamp":1762079775000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937821000752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0002937821000752"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2021.01.020","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2021.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}